LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 1 | J22 | 72 | hr | 1235 | 2458 | 4156 | 0.5914 | 0.4186 |
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 2 | J22 | 72 | hr | 1235 | 2648 | 4156 | 0.6371 | 0.4836 |
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 3 | J22 | 72 | hr | 1235 | 2373 | 4156 | 0.5710 | 0.3895 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 1 | M10 | 72 | hr | 1235 | 1776 | 4156 | 0.4273 | 0.1851 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 2 | M10 | 72 | hr | 1235 | 1754 | 4156 | 0.4220 | 0.1776 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 3 | M10 | 72 | hr | 1235 | 1835 | 4156 | 0.4415 | 0.2053 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 1235 | 3588 | 4156 | 0.8633 | 0.8055 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 1235 | 3663 | 4156 | 0.8813 | 0.8312 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 1235 | 3433 | 4156 | 0.8260 | 0.7524 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 1235 | 1438 | 4156 | 0.3460 | 0.0694 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 1235 | 1653 | 4156 | 0.3977 | 0.1430 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 1235 | 1495 | 4156 | 0.3597 | 0.0889 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 1 | L22 | 72 | hr | 1235 | 3185 | 4156 | 0.7663 | 0.6675 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 2 | L22 | 72 | hr | 1235 | 3324 | 4156 | 0.7998 | 0.7151 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 3 | L22 | 72 | hr | 1235 | 3509 | 4156 | 0.8443 | 0.7784 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 1235 | 3190 | 4156 | 0.7675 | 0.6692 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 1235 | 2992 | 4156 | 0.7199 | 0.6014 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 1235 | 3401 | 4156 | 0.8183 | 0.7415 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 1 | G10 | 72 | hr | 1235 | 1982 | 4156 | 0.4769 | 0.2556 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 2 | G10 | 72 | hr | 1235 | 1944 | 4156 | 0.4677 | 0.2426 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 3 | G10 | 72 | hr | 1235 | 2217 | 4156 | 0.5334 | 0.3361 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 1 | F04 | 72 | hr | 1235 | 761 | 4156 | 0.1831 | -0.1624 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 2 | F04 | 72 | hr | 1235 | 816 | 4156 | 0.1963 | -0.1436 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 3 | F04 | 72 | hr | 1235 | 755 | 4156 | 0.1817 | -0.1645 |
MCF7 | CGP60474 | 0.37 | uM | LJP6 | 1 | G04 | 72 | hr | 1235 | 547 | 4156 | 0.1316 | -0.2357 |